Literature DB >> 2086454

Short-term exposure of rat pancreatic islets to human interleukin-1 beta increases cellular uptake of calcium.

L A Borg1, D L Eizirik.   

Abstract

Interleukin-1 (IL-1) may be one of the effector molecules involved in the destruction of the pancreatic islet B cells resulting in insulin-dependent diabetes mellitus. Isolated islets exposed to IL-1 show an acutely increased substrate metabolism and insulin release, which is followed by a metabolic and functional suppression. Since an increased cellular uptake of calcium in the islets may be associated with both nutrient-induced insulin release and cell damage, the effects of recombinant IL-1 beta (rIL-beta) on net cellular calcium uptake by isolated rat pancreatic islets were investigated. In short-term experiments the islets were exposed to 25 U/ml rIL-1 beta for 120 min in the presence of 1.7 mM or 16.7 mM glucose, or 16.7 mM glucose plus 5 mM verapamil. In these experiments rIL-1 beta induced an increase both in net cellular uptake of calcium and in insulin release only in the presence of 16.7 mM glucose. The stimulatory effect of rIL-1 beta at 16.7 mM glucose was blocked by verapamil. By long-term experiments, under tissue culture conditions in the presence of 11.1 mM glucose, islet net calcium uptake, insulin release and glucose oxidation were measured at different time points over a 24-h period. During the first 2 h of incubation 25 U/ml rIL-1 beta effected a significant increase of net calcium uptake, insulin release and glucose oxidation. However, after 4-5 h of incubation with the cytokine no such stimulatory effects were seen. After longer incubations with rIL-1 beta all the islet functions studied were suppressed.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2086454     DOI: 10.1016/0165-2478(90)90155-j

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  7 in total

1.  Cytokines suppress human islet function irrespective of their effects on nitric oxide generation.

Authors:  D L Eizirik; S Sandler; N Welsh; M Cetkovic-Cvrlje; A Nieman; D A Geller; D G Pipeleers; K Bendtzen; C Hellerström
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

2.  Basal expression of cyclooxygenase-2 and nuclear factor-interleukin 6 are dominant and coordinately regulated by interleukin 1 in the pancreatic islet.

Authors:  C H Sorli; H J Zhang; M B Armstrong; R V Rajotte; J Maclouf; R P Robertson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

3.  Short term exposure of beta cells to low concentrations of interleukin-1β improves insulin secretion through focal adhesion and actin remodeling and regulation of gene expression.

Authors:  Caroline Arous; Pedro G Ferreira; Emmanouil T Dermitzakis; Philippe A Halban
Journal:  J Biol Chem       Date:  2015-01-13       Impact factor: 5.157

4.  Importance of mitochondrial superoxide dismutase expression in insulin-producing cells for the toxicity of reactive oxygen species and proinflammatory cytokines.

Authors:  S Lortz; E Gurgul-Convey; S Lenzen; M Tiedge
Journal:  Diabetologia       Date:  2005-06-29       Impact factor: 10.122

5.  Interleukin-1 signaling contributes to acute islet compensation.

Authors:  Catherine Hajmrle; Nancy Smith; Aliya F Spigelman; Xiaoqing Dai; Laura Senior; Austin Bautista; Mourad Ferdaoussi; Patrick E MacDonald
Journal:  JCI Insight       Date:  2016-04-07

Review 6.  Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes.

Authors:  Marc Y Donath; Joachim Størling; Kathrin Maedler; Thomas Mandrup-Poulsen
Journal:  J Mol Med (Berl)       Date:  2003-07-18       Impact factor: 4.599

7.  Excessive food intake, obesity and inflammation process in Zucker fa/fa rat pancreatic islets.

Authors:  Myriam Chentouf; Gregor Dubois; Céline Jahannaut; Françoise Castex; Anne Dominique Lajoix; René Gross; Sylvie Peraldi-Roux
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.